ATE532792T1 - Künstliches cpg einzelstrang oligodeoxynukleotid und dessen antivirale anwendungen - Google Patents
Künstliches cpg einzelstrang oligodeoxynukleotid und dessen antivirale anwendungenInfo
- Publication number
- ATE532792T1 ATE532792T1 AT10174994T AT10174994T ATE532792T1 AT E532792 T1 ATE532792 T1 AT E532792T1 AT 10174994 T AT10174994 T AT 10174994T AT 10174994 T AT10174994 T AT 10174994T AT E532792 T1 ATE532792 T1 AT E532792T1
- Authority
- AT
- Austria
- Prior art keywords
- virus
- odns
- stranded
- cpg
- artificial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 03146157 CN1289520C (zh) | 2003-07-25 | 2003-07-25 | 具有抗流感病毒的含CpG单链脱氧寡核苷酸 |
CNB031562248A CN1304412C (zh) | 2003-09-05 | 2003-09-05 | 抗单股正链RNA病毒人工合成的含CpG单链脱氧寡核苷酸 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE532792T1 true ATE532792T1 (de) | 2011-11-15 |
Family
ID=34137222
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04762006T ATE502949T1 (de) | 2003-07-25 | 2004-07-26 | Das künstliche cpg single strand deoxidation- oligonukleotid und dessen antivirale anwendungen |
AT10174994T ATE532792T1 (de) | 2003-07-25 | 2004-07-26 | Künstliches cpg einzelstrang oligodeoxynukleotid und dessen antivirale anwendungen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04762006T ATE502949T1 (de) | 2003-07-25 | 2004-07-26 | Das künstliche cpg single strand deoxidation- oligonukleotid und dessen antivirale anwendungen |
Country Status (8)
Country | Link |
---|---|
US (1) | US7491706B2 (de) |
EP (2) | EP1650218B1 (de) |
JP (1) | JP4809220B2 (de) |
KR (1) | KR101146203B1 (de) |
AT (2) | ATE502949T1 (de) |
CA (1) | CA2533434C (de) |
DE (1) | DE602004031946D1 (de) |
WO (1) | WO2005014611A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006056142A1 (fr) * | 2004-11-29 | 2006-06-01 | Changchun Huapu Biotechnology Co., Ltd. | Desoxynucleotides cpg a brin unique a utiliser comme adjuvant |
CN1865275B (zh) | 2005-05-17 | 2011-06-15 | 长春华普生物技术有限公司 | 对人b细胞肿瘤有治疗作用的人工合成的单链脱氧核苷酸 |
JP5759445B2 (ja) | 2009-03-25 | 2015-08-05 | ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | 病原体に対する哺乳類先天性免疫抵抗性の刺激のための組成物 |
KR101452830B1 (ko) * | 2012-04-06 | 2014-10-21 | 아이진 주식회사 | 두 가지 항암물질을 동시에 제공하는 대장균 균주 |
WO2016044839A2 (en) | 2014-09-19 | 2016-03-24 | The Board Of Regents Of The University Of Texas System | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds |
WO2021249116A1 (en) | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Coronavirus vaccine compositions, methods, and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999051259A2 (en) * | 1998-04-03 | 1999-10-14 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
US6977245B2 (en) * | 1999-04-12 | 2005-12-20 | The United States Of America As Represented By The Department Of Health And Human Services | Oligodeoxynucleotide and its use to induce an immune response |
CN1280303C (zh) * | 2003-05-28 | 2006-10-18 | 长春华普生物技术有限公司 | 人工合成的含CpG单链脱氧寡核苷酸及其抗SARS病毒作用 |
-
2004
- 2004-07-26 CA CA2533434A patent/CA2533434C/en not_active Expired - Fee Related
- 2004-07-26 EP EP04762006A patent/EP1650218B1/de active Active
- 2004-07-26 DE DE602004031946T patent/DE602004031946D1/de active Active
- 2004-07-26 US US10/565,718 patent/US7491706B2/en active Active
- 2004-07-26 JP JP2006521375A patent/JP4809220B2/ja active Active
- 2004-07-26 EP EP10174994A patent/EP2264046B1/de active Active
- 2004-07-26 WO PCT/CN2004/000863 patent/WO2005014611A1/zh active Application Filing
- 2004-07-26 AT AT04762006T patent/ATE502949T1/de not_active IP Right Cessation
- 2004-07-26 AT AT10174994T patent/ATE532792T1/de active
- 2004-07-26 KR KR1020067001765A patent/KR101146203B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20070155683A1 (en) | 2007-07-05 |
EP2264046A1 (de) | 2010-12-22 |
EP1650218A4 (de) | 2008-07-02 |
EP1650218A1 (de) | 2006-04-26 |
ATE502949T1 (de) | 2011-04-15 |
CA2533434A1 (en) | 2005-02-17 |
EP2264046B1 (de) | 2011-11-09 |
US7491706B2 (en) | 2009-02-17 |
JP2006528491A (ja) | 2006-12-21 |
DE602004031946D1 (de) | 2011-05-05 |
KR20060054354A (ko) | 2006-05-22 |
EP1650218B1 (de) | 2011-03-23 |
CA2533434C (en) | 2011-07-05 |
KR101146203B1 (ko) | 2012-05-25 |
JP4809220B2 (ja) | 2011-11-09 |
WO2005014611A1 (fr) | 2005-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR21C1037I1 (fr) | Clades de virus adéno associés (aav), séquences, vecteurs les contenant et leurs utilisations | |
WO2003070193A3 (en) | RNA interference mediated inhibition of HIV gene expression using short interfering nucleic acid (siNA) | |
DK3222722T3 (da) | Antisense-design | |
SI2287305T2 (en) | WITH RNA-INTERFERENCO-DELIVERED INHIBITION OF GEN expression by the use of a small interfering nucleic acid (SIN) | |
WO2006121464A3 (en) | Compositions for treating respiratory viral infections and their use | |
WO2004039829A3 (en) | Use of cpg oligonucleotides in the treatment of hepatitis c virus infection | |
EP2284268A3 (de) | Konservierte HBV- und HCV-Sequenzen zur Genausschaltung | |
ATE373671T1 (de) | Aminooxy-modifizierte oligonukleotide | |
CA2457528A1 (en) | Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina) | |
WO2006047842A3 (en) | Modified nucleosides for rna interference | |
DE69403642T2 (de) | 7-deazapurin modifizierte oligonukleotide | |
CY1108870T1 (el) | Αντιπαραλληλα ολιγονουκλεοτιδια (odn) κατα της smad7 και χρησεις στον ιατρικο τομεα τους | |
DE602004030583D1 (de) | Oligonukleotidanalog und verfahren zur behandlung von flavivirusinfektionen | |
ATE346918T1 (de) | Auf beta-arabinose, und dessen analogen, basierte antisense oligonukleotide | |
ATE532792T1 (de) | Künstliches cpg einzelstrang oligodeoxynukleotid und dessen antivirale anwendungen | |
IL153388A0 (en) | Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof | |
BRPI9800337A (pt) | par de iniciadores de oligonucleotídeos para a amplificação de ácido nucléico de tipo 1 (hiv-1) de vírus de imunodeficiência humana, conjunto de iniciadores, kits para detectar o dito ácido nucléico, bem como processo para referida amplificação. | |
WO2004078941A3 (en) | Modulation of gene expression using dna-rna hybrids | |
ATE281179T1 (de) | Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür | |
DE60110244D1 (de) | Chimerische antisense-oligonukleotide aus arabinofuranose-analogen und deoxyribose-nukleotide | |
DE60213406D1 (de) | Pharmakologische anwendungen von mitochondriellen dna assays | |
WO2003031459A3 (de) | Modulation der expression stat-1-abhängiger gene | |
WO2004035758A3 (en) | Rna-based inhibitory oligonucleotides | |
PT1254663E (pt) | Agente antiviral | |
DE60035680D1 (de) | Komplette gensequenz des esel-leukozyten-impfstoffstammes des equinen infektiösen anemievirus und ihre anwendung |